MADP-MXEP方案治疗复发与难治性非霍奇金淋巴瘤的近期及远期效果
出处
《实用癌症杂志》
2005年第3期312-313,共2页
The Practical Journal of Cancer
参考文献7
-
1孙艳丽,陈武,王立波.I MVp-16方案联合顺铂治疗难治性非霍奇金淋巴瘤的近期疗效(附29例报告)[J].中国肿瘤临床与康复,2002,9(5):79-80. 被引量：3
-
2Horwitz SM,Negrin RS, Blume KG,et al. Rituximab as adjuvant to high-dose therapy and autologous hematopioetic cell transplantation for aggressive non-Hodgkin lymphoma[J]. Blood ,2004, 103(3) :777.
-
3Julie M, Vose, Philip J, Bierman, Charles, et al. Phase I trial of Iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin, s lymphoma[ J ]. Journal of Clinical Oncology, 2005,3 (23) : 461.
-
4朱尊民,张茵,藏玉柱.造血干细胞支持下大剂量LACE方案对27例难治复发性淋巴瘤疗效观察[J].中国肿瘤临床,2005,32(2):89-91. 被引量：1
-
5Bezwoda W, Rastogi RB,Valta AE. Long-tern result of multicentre randomized,comparative phase Ⅲ trial of CHOP versus CNOP regimens in patients with intermediate and high-grade non-Hodgkin, s lymphoma. Excerpta Media Section 16[J]. Cancer,1995,101(5):328.
-
6张宪真,陈随芹.BEPP方案治疗复发与难治性非霍奇金淋巴瘤近期疗效[J].河南肿瘤学杂志,2002,15(3):180-181. 被引量：2
-
7苏震雄.BLM、VDS、CTX、Pred联合治疗复发与难治性非霍奇金淋巴瘤[J].白血病．淋巴瘤,2003,12(5):289-290. 被引量：1
二级参考文献20
-
1刘洪民 马献图 等.顺铂治疗恶性淋巴瘤43例临床疗效初步总结[J].中华肿瘤杂志,1995,7(4):286-286.
-
2黄雪珍 黄诚 等.Vp-16为主的联合方案治疗难治性恶淋巴瘤16例近期疗效分析[J].癌症,1989,8(6):489-489.
-
3Fisher R l,Gaynor E R,Dahlberg S,et al. Comparion of a standard regimen(CHOP) with three intensive chemotherapy regimen for advanced non-Hodgkin's lymphoma[J]. N Engl J Med,1993,328(14) : 1 002- 1006.
-
4Philip T.Guglielmic.Hagenbeek A ,et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma [J]. New Engl J Med,1995,333:1540.
-
5Jua Andrzej Walewski, Joanna Romejko-Jarosinska, Jacek Zwolinski,et al. DHAP chemotherapy for recurrent/refractory lymphoma-five year follow up of 112 patients[C]. ASCO Abstract. 2001 : 1161.
-
6Vose J M. Current approaches to the management of nonHodgkin's lymphoma [J]. Semin Oncol, 1998, 2,5 (4) : 483 -491.
-
7Seyfarth B, Kuse R, Sonnen R, et al. Autolgous stem cell transplantation for follicular lymphoma:no benefit for early transplant [J] ? Ann Hematol, 2001, 80(7):398～405
-
8Stockerl-Goldstein KE, Horning SJ, Negrin RS, et al. Influence of preparatory regimen and source of hematopoietic cells on outcome of auto-transplantation for non-Hodgkin's lymphoma [J]. Biol Blood Marrow Transplant, 1996, 2(2):76～85
-
9Vey N, Blaise D, Tiberghien P, et al. A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphoma [J]. Leuk Lymph, 1996, 21(2):107～114
-
10Horwitz SM, Negrin RS, Blume KG, et al. Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive Non-Hodgkin lymphoma [J]. Blood, 2004,103(3):777～7830-06
共引文献3
-
1陆紫敏,朱海平,修冰,付建非,薄兰君,顾凤英.TCOP联合平阳霉素治疗中高度非霍奇金淋巴瘤的临床研究[J].中国肿瘤临床,2004,31(11):617-619. 被引量：6
-
2侯淑玲,张巧花,王军,贺建霞,郑玉萍.三氧化二砷(As_2O_3)治疗难治性恶性淋巴瘤近期疗效[J].中国肿瘤临床,2005,32(24):1425-1426. 被引量：5
-
3朱家斌,丁邦和,陈侃侃.IEPD方案治疗复发和难治性非霍奇金淋巴瘤疗效初步评价[J].实用临床医药杂志,2007,11(6):66-67. 被引量：1
-
1王丽娟（综述）,宋强（审校）.复发性与难治性多发性骨髓瘤的治疗进展[J].国际输血及血液学杂志,2011,34(6):517-522. 被引量：3
-
2张为民,巨爱平,郑义同,蒋芹.口服或静滴VP-16联合CTX、ADM和PDN方案治疗NHL疗效和毒性观察[J].河南肿瘤学杂志,2002,15(2):104-105.
-
3张秋霞,齐增平,马秋娥,马林霞,张改茹,张惠玲,王玉强,高红梅.TID方案治疗复发与难治性非霍奇金淋巴瘤102例分析[J].中国误诊学杂志,2011,11(36):8976-8976.
-
4张秋霞,程会娟.TID方案治疗复发与难治性非霍奇金淋巴瘤临床观察[J].临床误诊误治,2011,24(1):55-57. 被引量：2
-
5苏震雄.BLM、VDS、CTX、Pred联合治疗复发与难治性非霍奇金淋巴瘤[J].白血病．淋巴瘤,2003,12(5):289-290. 被引量：1
-
6李丹红,刘开蕾,王艳苹.VAD方案治疗多发性骨髓瘤疗效观察[J].牡丹江医学院学报,2007,28(2):42-42.
-
7郭长升,唐家宏,宋宗昌,朱璐.环孢素联合干扰素治疗复发难治性白血病[J].实用医药杂志,2007,24(2):174-174.
-
8陈建安,王肇炎.CHEP 和 CHOP 方案治疗非霍奇金淋巴瘤的疗效比较[J].中华肿瘤杂志,1997,19(3):209-211. 被引量：4
-
9张宝松,张伟恒,袁艳秋.CHEP方案治疗难治性复发性恶性淋巴瘤疗效观察[J].东南大学学报（医学版）,2003,22(5):333-334.
-
10刘剑平,侯梅,任莉,易成,罗德云.IFO、MIT、Vp-16联合治疗复发与难治性非霍奇金氏淋巴瘤[J].癌症,2000,19(12):1141-1142. 被引量：5
